The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index; none of the 124 sources its claims cite is checked for support yet.
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Open accessPublished version of a preprint
Abstract
The ability to derive retinal ganglion cells (RGCs) from human pluripotent stem cells (hPSCs) has led to numerous advances in the field of retinal research, with great potential for the use of hPSC-derived RGCs for studies of human retinal development, in vitro disease modeling, drug discovery, as well as their potential use for cell replacement therapeutics. Of all these possibilities, the use of hPSC-derived RGCs as a human-relevant platform for in vitro disease modeling has received the greatest attention, due to the translational relevance as well as the immediacy with which results may be obtained compared to more complex applications like cell replacement. While several studies to date have focused upon the use of hPSC-derived RGCs with genetic variants associated with glaucoma or other optic neuropathies, many of these have largely described cellular phenotypes with only limited advancement into exploring dysfunctional cellular pathways as a consequence of the disease-associated gene variants. Thus, to further advance this field of research, in the current study we leveraged an isogenic hPSC model with a glaucoma-associated mutation in the Optineurin (OPTN) protein, which plays a prominent role in autophagy. We identified an impairment of autophagic-lysosomal degradation and decreased mTORC1 signaling via activation of the stress sensor AMPK, along with subsequent neurodegeneration in OPTN(E50K) RGCs differentiated from hPSCs, and have further validated some of these findings in a mouse model of ocular hypertension. Pharmacological inhibition of mTORC1 in hPSC-derived RGCs recapitulated disease-related neurodegenerative phenotypes in otherwise healthy RGCs, while the mTOR-independent induction of autophagy reduced protein accumulation and restored neurite outgrowth in diseased OPTN(E50K) RGCs. Taken together, these results highlighted that autophagy disruption resulted in increased autophagic demand which was associated with downregulated signaling through mTORC1, contributing to the degeneration of RGCs.
Overview
CoChat Summary
TL;DR
In isogenic hPSC-derived RGCs, the glaucoma-associated OPTN(E50K) mutation impaired autophagic-lysosomal degradation, reduced mTORC1 signaling via AMPK activation, and produced selective neurodegenerative phenotypes. mTOR-independent autophagy induction with trehalose rescued neurite outgrowth and reduced protein accumulation, whereas mTORC1 inhibition reproduced degenerative phenotypes in healthy RGCs.
Key findings
- OPTN(E50K) RGCs had unchanged OPTN mRNA but 41.1 ± 5.2% lower OPTN protein and 28.1 ± 4.3% higher p62; proteomics identified 154 downregulated and 178 upregulated proteins, including altered autophagy- and ubiquitination-associated proteins.
- Autophagic-lysosomal degradation was impaired: LC3-OPTN colocalization was 10.7 ± 1.2% in wild-type vs 5.1 ± 0.6% in OPTN(E50K) RGCs; LC3-II, LAMP1, and LC3-II/I were increased (p = 0.016, p = 0.0018, p = 0.039), and LC3-RFP-GFP showed more autophagosomes in OPTN(E50K) RGCs (35.8 ± 2.5% vs 25.5 ± 2.8% wild-type, p = 0.0075).
- mTORC1 signaling was reduced: pS6Ser240/244 decreased (p = 0.0057), pAKTSer473 was unchanged (p = 0.854), and pAMPKThr172 increased (p = 0.0027); in the mouse ocular hypertension model, pS6 decreased (p = 0.011) and LC3-II, LAMP1, and LC3-II/I increased (p = 0.034, p = 0.0004, p = 0.042).
- OPTN(E50K) caused RGC-selective neurite deficits, while cortical neurons showed no significant differences; mTOR inhibitor KU0063794 caused dose-dependent neurite shortening in healthy RGCs, and trehalose reduced OPTN puncta, reduced LC3-II, sustained pS6, and protected neurites in OPTN(E50K) RGCs.
Methods
- Isogenic hPSC model: H7 hESC and patient iPSC lines with OPTN(E50K) or CRISPR-corrected controls, with or without a BRN3b-tdTomato-Thy1.2 reporter; retinal organoids were differentiated, RGCs purified by CD90.2/Thy1.2 MACS, and matured up to 4 weeks; hPSC-derived cortical neurons were used for comparison.
- Mouse glaucoma model: adult female C57BL/6 mice (2–3 months, 20.3–25.1 g) received unilateral magnetic microbead anterior chamber injection to elevate intraocular pressure, with sham controls; retinas were analyzed 2 weeks after.
- Main assays: qPCR, immunoblotting, immunostaining, LC3-RFP-GFP autophagosome maturation assay, neurite tracing/Sholl analysis, TMT LC-MS/MS proteomics, and glucose uptake; statistics used t-test or ANOVA with Tukey post hoc, p < 0.05.
Limitations
- Stated: mouse autophagy findings used whole retina rather than purified RGCs, which may explain the less robust disruption compared with human hPSC-RGCs; the lack of OPTN protein difference in ocular hypertensive vs control mouse retinas could be due to analysis of total retinal protein rather than RGC content.
- Stated: whether decreased LC3 recruitment by OPTN directly causes autophagy defects or is compensated by other autophagy receptors remains undetermined, and whether AMPK regulates autophagy directly or indirectly through mTORC1 suppression still needs determination; the study also did not compare RGCs with other projection neurons such as motor neurons.
- Evident from the text: hPSC-derived RGCs are described as a somewhat immature developmental stage, so findings may not fully capture adult human RGC biology; several experiments rely on technical replicates with small biological n (e.g., n = 3 biological replicates), which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 1 Not valid · 64 Not checked · 143 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While the level of OPTN mRNA was not significantly changed among wild-type and OPTN(E50K) RGCs”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“along with a 28.1 ± 4.3% increase in the autophagy receptor p62”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our results show that RGCs subjected to insulin deprivation exhibited reduced glucose uptake (Figure S10)”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Altered mTOR signaling and autophagy modulated RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Insulin deprivation also decreased the mTORC1 effector pS6Ser240/244 in OPTN(E50K) RGCs (Figure S9 L-N)”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Altered mTOR signaling and autophagy modulated RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found that the number of OPTN puncta were significantly decreased in OPTN-E50K RGCs compared to control RGCs following chloroquine treatment”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
135 more claims
Create a free account to see all 208 claims and to verify the 124 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 29
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Inhibition of mTOR signaling results in neurodegenerative phenotypes in otherwise healthy hPSC-RGCs
“pAMPKThr172 **p = 0.0292”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
“**p < 0.01, *p < 0.05”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Introduction
“identified a disruption in OPTN protein processing along with a decrease in autophagic flux in hPSC-RGCs”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > OPTN(E50K) hPSC-RGCs display autophagosome accumulation and impaired autophagic-lysosomal degradation
“increased LC3-II, LAMP1 and autophagic flux (LC3-II to LC3-I ratio) in OPTN(E50K) hPSC-RGCs”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897 · cited 1×
“…degradation, we inhibited autophago-some-lysosome fusion by treatment with chloroquine for 16 h prior to fixation, as previously described [42], where we found that the number of OPTN puncta were significantly decreased in OPTN-E50K RGCs compared to control RGCs following chloroquine…”
MethodNutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Cited by
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Zhang, Q., Xiang, S., Chen, X., Rong, Y., Huang, L., Chen, Z., Yao, K., Chen, W., Deng, C., & Wang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112545 · Cited by 28
Myeloid lineage C3 induces reactive gliosis and neuronal stress during CNS inflammation
Garton, T. P., Smith, M. D., Kesharwani, A., Gharagozloo, M., Oh, S., Na, C. H., Absinta, M., Reich, D. S., Zack, D. J., & Calabresi, P. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58708-3 · Cited by 18
Hao, H., Yu, B., Liu, X., Zhang, Y., & Xing, X.-L. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.04.04 · Cited by 7
Gomes, C., Huang, K.-C., Lavekar, S. S., Harkin, J., Prosser, C. G., Fang, Y., Kalem, C., Oblak, A. L., Zhang, C., & Meyer, J. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423682122 · Cited by 3
Self-citation
Metadata
- Authors
- Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., Di Polo, A., & Meyer, J. S.
- Affiliations
- Indiana University School of Medicine (US)
- Indiana University Indianapolis (US)
- Université de Montréal (CA)
- Corresponding author
- Meyer, Jason S.
- ORCID
- Venue
- Acta Neuropathologica Communications
- Published
- 2024-10-18
- Volume
- 12
- Issue
- 1
- Pages
- 164-164
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC11487784
- OpenAlex
- W4403513715
- Semantic Scholar
- 6d28e5c0a5de677d3a970287e3d24cbb9f71b576
- Cited by
- 19
- References
- 109
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 3
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- PubMed (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by-nc-nd)
- Funders
- National Eye Institute (R01EY033022, U24EY033269, R01EY030838)
- BrightFocus Foundation (G2020369, G2022003F)
- Glaucoma Research Foundation
- Indiana State Department of Health (26343)
- Fonds de Recherche du Québec - Santé (276181)
- Canadian Institutes of Health Research (458569)
- Gilbert Family Foundation (923016)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- optineurin, retinal ganglion cells, human pluripotent stem cells, glaucoma, neurodegeneration, autophagy, mTORC1 signaling, AMPK, ocular hypertension, neurite outgrowth, protein accumulation
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Autophagy, Humans, Retinal Ganglion Cells, Signal Transduction, Cell Cycle Proteins, Membrane Transport Proteins, Pluripotent Stem Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction. https://app.cochat.ai/papers/10.1186/s40478-024-01872-2
- The paper
- Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., Di Polo, A., & Meyer, J. S. (2024). Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-024-01872-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.